Skip to main content

GT Metabolic Solutions

Saint Michael, United States

GT Metabolic Solutions develops a minimally-invasive incision-less bypass technology for bariatric, metabolic, and digestive surgery.

$17.1M raised
Mar 2024
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GT Metabolic Solutions

How much funding has GT Metabolic Solutions raised?
GT Metabolic Solutions has raised $17.1M in total funding. The most recent round was Series B. The last funding was announced in March 2024.
Who are GT Metabolic Solutions's investors?
GT Metabolic Solutions's investors include HealthTech Capital, Ironwood Ventures, Ceros Capital Markets.
Where is GT Metabolic Solutions headquartered?
GT Metabolic Solutions is headquartered in Saint Michael, United States.
What does GT Metabolic Solutions do?
GT Metabolic Solutions develops a minimally-invasive incision-less bypass technology for bariatric, metabolic, and digestive surgery.
What stage is GT Metabolic Solutions at?
GT Metabolic Solutions is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"GT Metabolic Solutions — Funding & Investors." VCBacked, March 12, 2024, https://www.vcbacked.co/company/gt-metabolic-solutions. Accessed July 3, 2026.
APA
VCBacked. (2024). GT Metabolic Solutions — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/gt-metabolic-solutions
Wikipedia (cite web)
{{cite web |title=GT Metabolic Solutions — Funding & Investors |url=https://www.vcbacked.co/company/gt-metabolic-solutions |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .